CWA
Clarus Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,627
| Closed | -$632K | – | 97 |
|
2024
Q4 | $632K | Sell |
3,627
-35
| -1% | -$6.1K | 0.31% | 72 |
|
2024
Q3 | $620K | Sell |
3,662
-334
| -8% | -$56.5K | 0.32% | 69 |
|
2024
Q2 | $625K | Sell |
3,996
-72
| -2% | -$11.3K | 0.33% | 63 |
|
2024
Q1 | $614K | Buy |
4,068
+213
| +6% | +$32.1K | 0.35% | 63 |
|
2023
Q4 | $581K | Buy |
+3,855
| New | +$581K | 0.34% | 66 |
|
2023
Q2 | $565K | Buy |
3,783
+1,060
| +39% | +$158K | 0.34% | 59 |
|
2023
Q1 | $429K | Sell |
2,723
-12
| -0.4% | -$1.89K | 0.27% | 79 |
|
2022
Q4 | $437K | Buy |
2,735
+361
| +15% | +$57.6K | 0.29% | 75 |
|
2022
Q3 | $315K | Sell |
2,374
-38
| -2% | -$5.04K | 0.22% | 83 |
|
2022
Q2 | $341K | Buy |
2,412
+93
| +4% | +$13.1K | 0.24% | 76 |
|
2022
Q1 | $352K | Buy |
2,319
+301
| +15% | +$45.7K | 0.22% | 75 |
|
2021
Q4 | $311K | Buy |
2,018
+201
| +11% | +$31K | 0.18% | 81 |
|
2021
Q3 | $296K | Sell |
1,817
-5
| -0.3% | -$815 | 0.18% | 80 |
|
2021
Q2 | $311K | Buy |
1,822
+172
| +10% | +$29.4K | 0.19% | 80 |
|
2021
Q1 | $262K | Buy |
1,650
+234
| +17% | +$37.2K | 0.16% | 107 |
|
2020
Q4 | $249K | Buy |
1,416
+1
| +0.1% | +$176 | 0.17% | 110 |
|
2020
Q3 | $224K | Buy |
1,415
+122
| +9% | +$19.3K | 0.17% | 109 |
|
2020
Q2 | $224K | Buy |
+1,293
| New | +$224K | 0.19% | 112 |
|
2020
Q1 | – | Sell |
-1,435
| Closed | -$217K | – | 123 |
|
2019
Q4 | $217K | Buy |
+1,435
| New | +$217K | 0.14% | 126 |
|
2019
Q3 | – | Sell |
-1,438
| Closed | -$203K | – | 268 |
|
2019
Q2 | $203K | Buy |
1,438
+1,178
| +453% | +$166K | 0.15% | 107 |
|
2019
Q1 | $39K | Buy |
260
+10
| +4% | +$1.5K | 0.03% | 334 |
|
2018
Q4 | $31K | Hold |
250
| – | – | 0.05% | 328 |
|
2018
Q3 | $40K | Hold |
250
| – | – | 0.03% | 327 |
|
2018
Q2 | $33K | Buy |
+250
| New | +$33K | 0.03% | 348 |
|